FRESENIUS MEDICAL CARE AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.79 EUR | -3.00% |
|
+3.73% | -0.45% |
| Sales 2024 * | 19.65B 21.08B | Sales 2025 * | 20.36B 21.85B | Capitalization | 11.09B 11.9B |
|---|---|---|---|---|---|
| Net income 2024 * | 711M 763M | Net income 2025 * | 972M 1.04B | EV / Sales 2024 * | 1.07 x |
| Net Debt 2024 * | 9.86B 10.58B | Net Debt 2025 * | 9.22B 9.9B | EV / Sales 2025 * | 1 x |
| P/E ratio 2024 * |
15.7
x | P/E ratio 2025 * |
11.5
x | Employees | 119,845 |
| Yield 2024 * |
2.88% | Yield 2025 * |
3.46% | Free-Float | 67.83% |
More Fundamentals
* Assessed data
More news
Latest transcript on Fresenius Medical Care AG
More recommendations
More press releases
| 1 day | -3.00% | ||
| 1 week | +3.73% | ||
| Current month | +6.00% | ||
| 1 month | +8.06% | ||
| 3 months | +4.02% | ||
| 6 months | +18.84% | ||
| Current year | -0.45% |
1 week
36.87
40.38
1 month
34.1240.38
Current year
33.8841.62
1 year
30.1649.62
3 years
25.9571.14
5 years
25.9581.10
10 years
25.9593.82
| Managers | Title | Age | Since |
|---|---|---|---|
Helen Giza
CEO | Chief Executive Officer | 56 | 19-10-31 |
Martin Fischer
DFI | Director of Finance/CFO | 47 | 23-09-30 |
Franklin Maddux
CTO | Chief Tech/Sci/R&D Officer | 65 | 08-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Pascale Witz
BRD | Director/Board Member | 57 | 16-05-11 |
Shervin Korangy
BRD | Director/Board Member | 50 | 23-07-13 |
Marcus Kuhnert
BRD | Director/Board Member | 56 | 23-07-13 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 7.48% | 202 M€ | -.--% | ||
| 1.12% | 2 M€ | +13.56% | - | |
| 0.80% | 79 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 37.79 | -3.00% | 437,031 |
| 24-04-24 | 38.96 | -2.36% | 344,818 |
| 24-04-23 | 39.9 | +2.36% | 801,792 |
| 24-04-22 | 38.98 | +6.44% | 750,876 |
| 24-04-19 | 36.62 | +0.52% | 803,997 |
Delayed Quote Xetra, April 25, 2024 at 11:39 am EDT
More quotes
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Calendar
2024-05-06
- Q1 2024 Earnings Call
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
37.79
EUR
Average target price
39.01
EUR
Spread / Average Target
+3.22%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -0.45% | 12.22B | |
| -14.73% | 85.42B | |
| +16.05% | 84.38B | |
| +10.92% | 29.39B | |
| -12.73% | 17.49B | |
| -3.17% | 16.44B | |
| -1.78% | 15.28B | |
| -31.23% | 11.98B | |
| -2.51% | 11.71B | |
| +26.74% | 11.64B |
- Stock Market
- Equities
- FME Stock
